Literature DB >> 30352436

Ethyl Pyruvate Attenuates CaCl2-Induced Tubular Epithelial Cell Injury by Inhibiting Autophagy and Inflammatory Responses.

Jiawen Zhao, Jiwen Cheng, Chengyang Li, Mingbin Xu, Chenjun Ma, Lei Qin, Kai Yi, Naikai Liao.   

Abstract

BACKGROUND/AIMS: Nephrolithiasis is one of the most prevalent diseases of the urinary system. Approximately 80% of human kidney stones are composed of calcium oxalate (CaOx), and hypercalciuria is one of the most common metabolic disorders. Emerging evidence indicates that autophagy and inflammatory responses are related to the formation of CaOx nephrolithiasis. However, the roles of autophagy and inflammation in patients with hypercalciuria remain unclear. Ethyl pyruvate (EP) displays protective effects in experimental models of many illnesses. In this study, we investigated the protective effects of EP in vitro through its inhibition of autophagy and inflammatory responses after CaCl2-induced tubular epithelial cell injury.
METHODS: First, we cultured human tubular epithelial (HK-2) cells in the presence of various concentrations of CaCl2 (0, 0.1, 0.25, 0.5, 1.0, 1.5, and 2.0 mg/ml) for 12 h and EP (0, 1.0, 2.5, 5.0, and 10.0 mM) for 2 h to select the optimum concentration using the Cell Counting Kit-8 assay and lactate dehydrogenase (LDH) assay. Cells in culture were stimulated with CaCl2 (1.0 mg/ml, 12 h) with or without EP pretreatment (2.5 mM, 2 h). After the exposure, we detected the expression of inflammation-related proteins using an enzyme-linked immunosorbent assay and Western blot analysis. Finally, the levels of autophagy-related proteins were determined through Western blot analysis, and the number of GFP-LC3 dots and autophagic vacuoles was detected under confocal microscopy.
RESULTS: With the use of the Cell Counting Kit-8 assay and the LDH assay, we identified the optimum concentration for CaCl2 (1.0 mg/ml) treatment and EP pretreatment (2.5 mM). Our research indicated that CaCl2 can induce autophagy and inflammatory responses in HK-2 cells. Furthermore, treatment with EP prior to CaCl2 stimulation attenuated HK-2 cell injury by inhibiting autophagy and inflammation.
CONCLUSION: Our results provide evidence that EP attenuates CaCl2-induced injury of HK-2 cells by downregulating the expression of inflammation and autophagy proteins that may be associated with the inhibition of the high-mobility group box-1 (HMGB1)/toll-like receptor 4 (TLR4)/NF-κB pathway and the competitive interaction with Beclin-1 of HMGB1.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Autophagy; Ethyl pyruvate; Hypercalciuria; Inflammation; Nephrolithiasis; Tubular epithelial cell

Mesh:

Substances:

Year:  2018        PMID: 30352436     DOI: 10.1159/000494445

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  5 in total

1.  Ethyl pyruvate inhibits LPS induced IPEC-J2 inflammation and apoptosis through p38 and ERK1/2 pathways.

Authors:  Na Dong; Xinyao Xu; Chenyu Xue; Chensi Wang; Xinran Li; Chongpeng Bi; Anshan Shan
Journal:  Cell Cycle       Date:  2019-09-01       Impact factor: 4.534

2.  Exosomes from miR-20b-3p-overexpressing stromal cells ameliorate calcium oxalate deposition in rat kidney.

Authors:  Jing Shi; Junyao Duan; Huijie Gong; Yuewen Pang; Ling Wang; Yongji Yan
Journal:  J Cell Mol Med       Date:  2019-09-05       Impact factor: 5.310

3.  Role of ROS-Induced NLRP3 Inflammasome Activation in the Formation of Calcium Oxalate Nephrolithiasis.

Authors:  Yunlong Liu; Yan Sun; Juening Kang; Ziqi He; Quan Liu; Jihua Wu; Derong Li; Xiang Wang; Zhiwei Tao; Xiaofeng Guan; Wusheng She; Hua Xu; Yaoliang Deng
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

4.  The role of autophagy in calcium oxalate kidney stone: A systematic review of the literature.

Authors:  Hao Li; Yingjian Zhou; Wenchao Xu; Jihong Liu; Shaogang Wang; Hongyang Jiang
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

Review 5.  Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway.

Authors:  Ruihua Fan; Lvxia Wang; Benson O A Botchway; Yong Zhang; Xuehong Liu
Journal:  Front Mol Neurosci       Date:  2022-09-16       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.